AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

INTERNATIONAL BIOTECHNOLOGY TST PLC

Report Publication Announcement Oct 31, 2024

5163_rns_2024-10-31_b2761188-9646-4537-b2e2-2bc46cbecd23.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 4512K

Intl. Biotechnology Trust PLC

31 October 2024

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

Latest Factsheet and Blog

IBT's factsheet for the month ended 30 September 2024 is now available directly via its web page. Please click here , then 'latest factsheet'.

Healthcare has been a huge subject of debate in previous US elections, contributing to significant market volatility, but the topic is more muted this time. Clearly, it's important to understand how different outcomes may impact the biotech sector. In their latest blog post, Portfolio Managers Ailsa Craig and Marek Poszepczynski take a look at what to expect, with help from the history books….

The blog can be read here: https://www.schroders.com/en-gb/uk/individual/content/how-will-the-us-election-impact-biotechnology-/

To sign up for IBT updates by email, please click here .

ENDS

Enquiries:

Schroder Investment Management Limited

Charlotte Banks (Press)

Kirsty Preston

Kerry Higgins (Company Secretary)
020 7658 6000

020 7658 6000
Kaso Legg Communications (Financial PR)

Charles Gorman            

Henry Taylor

Effie Aye Maung Hider
[email protected]

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRALFLFXZBLXFBQ

Talk to a Data Expert

Have a question? We'll get back to you promptly.